219 related articles for article (PubMed ID: 9617031)
1. Gamma-hydroxybutyrate (GHB): a new drug of misuse.
Williams H; Taylor R; Roberts M
Ir Med J; 1998; 91(2):56-7. PubMed ID: 9617031
[TBL] [Abstract][Full Text] [Related]
2. Physostigmine for gamma-hydroxybutyrate coma: inefficacy, adverse events, and review.
Zvosec DL; Smith SW; Litonjua R; Westfal RE
Clin Toxicol (Phila); 2007; 45(3):261-5. PubMed ID: 17453877
[TBL] [Abstract][Full Text] [Related]
3. [A new drug reaches Switzerland: coma after intake of gamma-hydroxybutyrate (GHB)].
Iten PX; Oestreich A; Lips R; Brabetz M
Schweiz Med Wochenschr; 2000 Mar; 130(10):356-61. PubMed ID: 10763213
[TBL] [Abstract][Full Text] [Related]
4. Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma.
Zvosec DL; Smith SW; Porrata T; Strobl AQ; Dyer JE
Am J Emerg Med; 2011 Mar; 29(3):319-32. PubMed ID: 20825811
[TBL] [Abstract][Full Text] [Related]
5. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
[TBL] [Abstract][Full Text] [Related]
6. [Gamma-hydroxybutyrate, a new central nervous system stimulant].
Strange DG; Jensen D
Ugeskr Laeger; 1999 Dec; 161(50):6934-6. PubMed ID: 10643381
[TBL] [Abstract][Full Text] [Related]
7. [Gamma-hydroxybutyrate--an endogenous substance and a new central nervous system stimulant. Clinical aspects of acute poisoning].
Engelsen J; Christensen HR
Ugeskr Laeger; 1999 Dec; 161(50):6903-7. PubMed ID: 10643375
[TBL] [Abstract][Full Text] [Related]
8. [GHB--dangerous, addictive and uncontrollable "party drug"].
Persson SA; Eriksson A; Hallgren N; Eklund A; Berkowicz A; Druid H
Lakartidningen; 2001 Sep; 98(38):4026-31, 4033-5. PubMed ID: 11602959
[TBL] [Abstract][Full Text] [Related]
9. Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series.
Van Sassenbroeck DK; De Neve N; De Paepe P; Belpaire FM; Verstraete AG; Calle PA; Buylaert WA
Clin Toxicol (Phila); 2007; 45(5):533-8. PubMed ID: 17503262
[TBL] [Abstract][Full Text] [Related]
10. [First report of lethal gamma-hydroxybutyrate (GHB) intoxication after consumption of gamma-butyrolactone (GBL) in Lower Saxony].
Fieguth A; Albrecht K; Weller JP; Kühnle R; Teske J
Arch Kriminol; 2009; 223(1-2):45-51. PubMed ID: 19323150
[TBL] [Abstract][Full Text] [Related]
11. Reply to "Insufficient evidence that agitation is common in gamma-hydroxybutyrate (GHB) toxicity," submitted in response to our original article entitled, "Agitation is common in gamma-hydroxybutyrate toxicity," published in AJEM, May 2005.
Zvosec DL; Smith SW
Am J Emerg Med; 2006 May; 24(3):388-9. PubMed ID: 16635731
[No Abstract] [Full Text] [Related]
12. [Variety of symptoms after drug use of gamma-hydroxybutyric acid (GHB)].
Galldiks N; Kadow I; Bechdolf A; Fink GR; Klosterkötter J; Kuhn J
Fortschr Neurol Psychiatr; 2011 Jan; 79(1):21-5. PubMed ID: 21154180
[TBL] [Abstract][Full Text] [Related]
13. Gamma-hydroxybutyrate: a 30 month emergency department review.
Munir VL; Hutton JE; Harney JP; Buykx P; Weiland TJ; Dent AW
Emerg Med Australas; 2008 Dec; 20(6):521-30. PubMed ID: 19125832
[TBL] [Abstract][Full Text] [Related]
14. [Gamma-hydroxybutyrat (GHB)-dependence and -withdrawal in the case of previous alcohol dependence].
Richter C; Romanowski A; Kienast T
Psychiatr Prax; 2009 Oct; 36(7):345-7. PubMed ID: 19173170
[TBL] [Abstract][Full Text] [Related]
15. [Poisoning with central nervous system stimulants. Amphetamine, ecstasy, cocaine and gamma-hydroxybutyrate].
Christensen HR
Ugeskr Laeger; 1999 Dec; 161(50):6899. PubMed ID: 10643372
[No Abstract] [Full Text] [Related]
16. [Gamma-hydroxybutyrate--an endogenous substance and an intoxicant].
Hovda KE; Liberg JP; Nordby G; Jacobsen D
Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4390-3. PubMed ID: 9889613
[TBL] [Abstract][Full Text] [Related]
17. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management.
Li J; Stokes SA; Woeckener A
Ann Emerg Med; 1998 Jun; 31(6):729-36. PubMed ID: 9624313
[TBL] [Abstract][Full Text] [Related]
18. Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.
Miró Ò; Galicia M; Dargan P; Dines AM; Giraudon I; Heyerdahl F; Hovda KE; Yates C; Wood DM; Liakoni E; Liechti M; Jürgens G; Pedersen CB; O'Connor N; Markey G; Moughty A; Lee C; O'Donohoe P; Sein Anand J; Puiguriguer J; Homar C; Eyer F; Vallersnes OM; Persett PS; Chevillard L; Mégarbane B; Paasma R; Waring WS; Põld K; Rabe C; Kabata PM
Toxicol Lett; 2017 Aug; 277():84-91. PubMed ID: 28579487
[TBL] [Abstract][Full Text] [Related]
19. Gamma-hydroxybutyrate--a drug of abuse.
Drasbek KR; Christensen J; Jensen K
Acta Neurol Scand; 2006 Sep; 114(3):145-56. PubMed ID: 16911342
[TBL] [Abstract][Full Text] [Related]
20. Clinical course of gamma-hydroxybutyrate overdose.
Chin RL; Sporer KA; Cullison B; Dyer JE; Wu TD
Ann Emerg Med; 1998 Jun; 31(6):716-22. PubMed ID: 9624311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
